following interferon therapy Philadelphia chromosome-positive chronic myelogenous leukemia Detection of minimal residual disease by polymerase chain reaction in

[1]  M. Slovak,et al.  Persistence of bcr-able gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. , 1991, Transplantation.

[2]  G. Morgan,et al.  Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. , 1991, Blood.

[3]  C. Sawyers,et al.  Significance of residual leukaemia transcripts after bone marrow transplant for CML , 1990, The Lancet.

[4]  J. Gabert,et al.  DETECTION OF RESIDUAL bcr/abl TRANSLOCATION BY POLYMERASE CHAIN REACTION IN CHRONIC MYELOID LEUKAEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION , 1989, The Lancet.

[5]  D. Ginsburg,et al.  Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia , 1989 .

[6]  H. Kantarjian,et al.  Clinical investigation of human alpha interferon in chronic myelogenous leukemia. , 1987, Blood.

[7]  Kees Stam,et al.  Structural organization of the bcr gene and its role in the Ph′ translocation , 1985, Nature.

[8]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[9]  G. Canellos,et al.  Chronic granulocytic leukemia. , 1976, The Medical clinics of North America.

[10]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.